S. 3385 · 118th Congress (2023–2025)
A bill to prohibit contracting with certain biotechnology providers.
This bill prohibits federal contracting with certain biotechnology providers connected to foreign adversaries, with exceptions.
Specifically, the bill prohibits executive agencies from (1) procuring, obtaining, extending, or renewing a contract to procure or obtain any biotechnology equipment or service produced or provided by a biotechnology company of concern; or (2) entering into a contract or extending or renewing a contract that uses such equipment or service or that will require the direct use of such equipment or services. Those agencies may not obligate or expend loan or grant funds for such purposes.
A biotechnology company of concern includes BGI Group, MGI Group, Complete Genomics, any subsidiary, parent affiliate, or successor of such entities, and any entity that
- is subject to the jurisdiction, direction, or control of a foreign adversary;
- operates primarily in the biotechnology industry; and
- the Department of Defense (DOD) deems to pose a risk to national security.
DOD must determine, within 90 days after this bill's enactment, whether WuXi AppTec, Axbio, and any subsidiary, affiliate, or successor of such entities, or any other entity headquartered in or organized under the laws of China, is a biotechnology company of concern.
Executive agencies may waive the prohibitions on a case-by-case basis under specified circumstances.
Expired in Senate committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to committee
This bill’s path
This is S. 3385’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
Expired
- Sponsor
- Sen. Bill Hagerty (R-TN)
- Policy area
- Government Operations and Politics
- Subjects
- Congressional oversight
- Government information and archives
- Health technology, devices, supplies
- Public contracts and procurement
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Sources
- Congress.gov action
- Senate
Expired
Introduced → Referred to Senate Homeland Security and Governmental Affairs → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in Senate |
Titles (1)
A bill to prohibit contracting with certain biotechnology providers.
Display title, Official title · Introduced in Senate